VEGFA and cancer: Most of these cancers present inactivation/mutation in the von Hippel-Lindau (VHL) gene, inducing the stabilization of hypoxia-inducible factor 1 and 2 α (HIF1 and 2α) and the over-expression of their target genes, including the vascular endothelial growth factor (VEGF) [3].